Dr. Swickard studies the effectiveness of different tests for detecting SARS-CoV-2, the virus that causes COVID-19. His research emphasizes the importance of identifying asymptomatic cases, which are individuals who carry the virus without exhibiting symptoms. He evaluates various molecular diagnostic tests to determine how accurately they can diagnose COVID-19 and how well they perform in distinguishing positive cases from negative ones. This work is vital for public health, as accurate testing is crucial for controlling the pandemic and ensuring the safety of communities.
Key findings
In a study involving 184 samples, the Abbott ID NOW test identified 91% of positive cases, while the DiaSorin Simplexa and Roche Cobas tests achieved a perfect accuracy rate of 100%.
Both the DiaSorin Molecular Simplexa and Roche Cobas tests showed agreement in results 97% of the time, highlighting their reliability in detecting asymptomatic carriers of the virus.
All three tests evaluated in Dr. Swickard's research successfully confirmed negative cases without any false negatives, ensuring that individuals who are not infected do not receive misleading results.
Frequently asked questions
Does Dr. Swickard study COVID-19?
Yes, Dr. Swickard focuses on the detection and diagnosis of COVID-19 through various testing methods.
What COVID-19 testing methods has Dr. Swickard researched?
He has researched several tests, including the Abbott ID NOW, DiaSorin Simplexa, and Roche Cobas, to evaluate their accuracy in detecting the virus.
Is Dr. Swickard's work relevant to patients without symptoms?
Yes, his research is crucial for identifying asymptomatic carriers of COVID-19, which helps in controlling the spread of the virus.
How accurate are the tests Dr. Swickard studies?
The tests studied by Dr. Swickard, such as the DiaSorin Simplexa and Roche Cobas, have shown up to 100% accuracy in detecting COVID-19.
Why is accurate COVID-19 testing important?
Accurate testing is vital for ensuring patients receive the correct diagnosis and for public health measures to prevent the spread of the virus.
Publications in plain English
Detection of SARS-CoV-2 infection in asymptomatic populations using the DiaSorin molecular Simplexa and Roche Cobas EUA assays.
2022
Diagnostic microbiology and infectious disease
Antonara S, Ozbolt P, Landon L, Fatica L, Pleasant T +4 more
Plain English This study looked at two COVID-19 testing methods, the DiaSorin Molecular Simplexa and the Roche Cobas, to see how well they detect the virus in people who show no symptoms. It found that both tests agree 97% of the time, meaning they often give the same results. This is important because accurate testing can help identify asymptomatic carriers of the virus, which is crucial for controlling the spread of COVID-19.
Who this helps: This helps patients, particularly those who might be carrying the virus without knowing it, as well as public health officials.
Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2.
2020
American journal of clinical pathology
Cradic K, Lockhart M, Ozbolt P, Fatica L, Landon L +6 more
Plain English This study looked at how well three tests for COVID-19 work: Abbott ID NOW, DiaSorin Simplexa, and Roche cobas, using samples from 184 swabs. The results showed that the Abbott test correctly identified 91% of positive cases, while the other two tests performed even better at 100%. All three tests were also great at confirming negative cases, leaving no false negatives. Finding effective testing methods is crucial for accurately diagnosing COVID-19, especially in emergencies.
Who this helps: This helps patients and healthcare providers by ensuring reliable COVID-19 testing options.
Stella Antonara Patrick Ozbolt Lorie Landon Lisa Fatica Nicholas Wongchaowart Tamra Pleasant Andrew Drury Kendall W Cradic Kendall Cradic Marie Lockhart
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.